Deudextromethorphan

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameDeudextromethorphan
Drug Alias Name氘右美沙芬Hexadeuterodextromethorphan六氘代右美沙芬deudextromethorphanumdeudextrometorfano +[10] 
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsP-glycoprotein 1 inhibitorsSigma opioid receptor agonists
TargetsSigma opioid receptorGlutamate [NMDA] receptorP-glycoprotein 1
Therapy Area/IndicationsBody Dysmorphic DisordersSchizophreniaDisruptive, Impulse Control, and Conduct Disorders +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[29] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaIND
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Consumer Health SaOtsuka Pharmaceutical Development & Commercialization IncStanford University +[10] 
Inactive CompaniesN/A
Active IndicationsBody Dysmorphic DisordersObsessive-Compulsive DisorderAnxiety Disorders +[5] 
Inactive IndicationsSchizophreniaDisruptive, Impulse Control, and Conduct Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia